Autosomal Dominant Polycystic Kidney Disease: Clinical Assessment of Rapid Progression

Conclusions: The ERA-EDTA WGIKD/ERBP algorithm provides a valuable means of identifying in routine clinical practice patients who may be eligible for treatment with tolvaptan. The impact of a new threshold for age and eGFR may increase the percentage of patients to be treated.Am J Nephrol 2018;48:308 –317
Source: American Journal of Nephrology - Category: Neurology Source Type: research